Sorrento Therape (SRNE) stock news · rev $62.8M
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
This SRNE news page leads with what Sorrento Therape filed — not a scraped headline mill.
No cached 8-K sentence for SRNE yet. We will not pad this page with generic market recap.
Latest reported SRNE revenue for 2022-12-31 was $62.8M. Net income was -$572.8M. Revenue was down 48.5% from 2017-09-30 to 2022-12-31. SRNE currently screens at market cap $385.9K.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the SRNE stock page; for the tape open the quote page.
SRNE stock news FAQ
What are SRNE's latest revenue and net income?
Latest cached Sorrento Therape (SRNE) revenue for Dec 31, 2022 was $62.8M. Net income was -$572.8M. Statements: https://lician.com/financials/srne
How did SRNE revenue change from the prior cached period?
Cached Sorrento Therape (SRNE) revenue was down 48.5% from $121.9M (Sep 30, 2017) to $62.8M (Dec 31, 2022). Statements: https://lician.com/financials/srne
What is SRNE's market cap?
Sorrento Therape (SRNE) market cap is $385.9K on the latest cached fundamentals snapshot.
What kind of company is SRNE?
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Where is SRNE stock news listed?
Cached stock news for Sorrento Therape (SRNE) is listed at https://lician.com/news/srne. Filings: https://lician.com/sec/srne
Not investment advice.